Wednesday, November 18, 2020 4:38:02 PM
Will be very nice to see a PR before opening bell tomorrow telling us Dr. Drew Pinsky's new informercial dropping in time for Christmas.
Covid has picked up. The country needs iWANDS and Rovers!
MORE DD FOR YOU TO READ. FACTS NOT FEAR!
2BILLION IN THERE! CELLPHONE PATENT PENDING!! GREEK DEAL ABOUT TO BE UPDATED AND LETS GO OPTI!!
Note 9 – SUBSEQUENT EVENTS
Management has reviewed events between March 31, 2020 to the date that the financials were issued, and other than the
following there were no other significant events identified for disclosure.
WE have retained the services of a professional patent evaluation firm to accurately evaluate the two patents we have filed
which were disclosed at year end:
• US patent pending for the integration of UVC-LED Sterilization technology for integration with cell phones and
tablets.
• US patent pending for the integration of Thermal Digital Temperature Scanning technology for integration with
cell phones and tablets.
Based on preliminary evaluations the company has conservatively estimated a valuation of $5 million for both patents. The
valuations of the patents are not included in this financial statement.
Our recent expansion into volume and wholesale personal protection equipment (PPE) has led to a significant increase in our
sales and distribution; recently securing a purchase order in excess of $2 Billion for specific brand PPE products to an
International commodities organization.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v2.1 December 2019)
32
We have also recently completed distributorship agreements our lines of UV and UVC, and PPE products and equipment in
both the US and International markets, including the finalization of the Greek distributorship
In addition we have recently introduced a series of biomasks equivalent to N-99 protection levels surpassing medical grade
requirements for face coverings.
The company’s product website www.optecuvc.com now offers all product lines available for immediate shipping
https://backend.otcmarkets.com/otcapi/company/financial-report/264089/content
https://www.otcmarkets.com/stock/OPTI/disclosure
Covid has picked up. The country needs iWANDS and Rovers!
MORE DD FOR YOU TO READ. FACTS NOT FEAR!
2BILLION IN THERE! CELLPHONE PATENT PENDING!! GREEK DEAL ABOUT TO BE UPDATED AND LETS GO OPTI!!
Note 9 – SUBSEQUENT EVENTS
Management has reviewed events between March 31, 2020 to the date that the financials were issued, and other than the
following there were no other significant events identified for disclosure.
WE have retained the services of a professional patent evaluation firm to accurately evaluate the two patents we have filed
which were disclosed at year end:
• US patent pending for the integration of UVC-LED Sterilization technology for integration with cell phones and
tablets.
• US patent pending for the integration of Thermal Digital Temperature Scanning technology for integration with
cell phones and tablets.
Based on preliminary evaluations the company has conservatively estimated a valuation of $5 million for both patents. The
valuations of the patents are not included in this financial statement.
Our recent expansion into volume and wholesale personal protection equipment (PPE) has led to a significant increase in our
sales and distribution; recently securing a purchase order in excess of $2 Billion for specific brand PPE products to an
International commodities organization.
OTC Markets Group Inc.
OTC Pink Basic Disclosure Guidelines (v2.1 December 2019)
32
We have also recently completed distributorship agreements our lines of UV and UVC, and PPE products and equipment in
both the US and International markets, including the finalization of the Greek distributorship
In addition we have recently introduced a series of biomasks equivalent to N-99 protection levels surpassing medical grade
requirements for face coverings.
The company’s product website www.optecuvc.com now offers all product lines available for immediate shipping
https://backend.otcmarkets.com/otcapi/company/financial-report/264089/content
https://www.otcmarkets.com/stock/OPTI/disclosure
